Ozempic and similar GLP-1 drugs are fueling a wave of mass tort litigation. In this Trial Lawyer View episode, Michael Lynch shares what trial lawyers need to know about emerging claims, signature injuries, and strategies to hold pharmaceutical companies accountable.
Mass tort firms spend countless hours chasing medical records. Learn how Angeion Group’s blend of AI, nursing expertise, and client engagement helps trial lawyers validate cases, reduce bottlenecks, and scale growth.
Michael Lynch is a nationally recognized trial attorney leading a complex litigation firm advocating for victims of defective drugs, toxic exposure, NEC, personal injury, and more.
Troy Rafferty, top trial lawyer and shareholder at Rafferty Domnick Cunningham & Yaffa, known for landmark mass tort verdicts and billion-dollar settlements.